Industrial production of "Sputnik V" vaccine to be launched in Belarus late March

Industrial production of the "Sputnik V" vaccine is planned to be launched in Belarus late March. The monthly production volume will make 500 thousand doses. Vaccination of the population of Belarus is the primary objective. When the opportunity appears, the vaccine will be exported. Late February, the first lot of the vaccine was produced at a Belarusian pharmaceutical enterprise. It is now under tests in Russia for its stability and efficiency. Regarding the internal medicine market, almost a half of its volume is occupied by local products. Last year, the Belarusian medicines were exported to 31 countries worldwide.